Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Business Machines Corp (IBM) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance

International Business Machines CorpTrade
Relay Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

International Business Machines Corp vs Relay Therapeutics Inc. Common Stock — how do they compare? International Business Machines Corp trades at $226.67 (market cap $213.50B), while Relay Therapeutics Inc. Common Stock trades at $17.88 (market cap $3.82B). The key difference: International Business Machines Corp is far larger — about 55.9× Relay Therapeutics Inc. Common Stock's market cap, and International Business Machines Corp pays a 2.98% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold International Business Machines Corp for 88 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.

IBMRLAY
Market Cap
$213.50B$3.82B
Volume
8,908,6874,332,079
Sector
TechnologyHealth
52-Week High
$329.23$20.75
52-Week Low
$205.77$6.03
Typical Hold Time
88 Days0 Days
Enterprise Value
$270.64B$2.93B
Dividend Yield
2.98%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

International Business Machines Corp

IBM stock trades at $227.13, up 3.0% today, showing resilience after recent volatility. The company reported strong Q4 2025 and Q1 2026 earnings beats but missed Q2 2026 expectations. Revenue growth accelerated to $67.54B in 2025 with net income margin improving to 15.52%. Technical indicators show bearish momentum with RSI at 71.56 suggesting overbought conditions, while analyst consensus remains positive with a $255.50 price target.

IBM's pivot to hybrid cloud and AI consulting shows promise with $5.5B generative AI bookings, though execution risks persist. The stock offers 12.5% upside to consensus target but faces headwinds from mainframe cyclicality and competitive pressure. Cash flow trends weakened in 2025 with negative net cash flow, requiring monitoring of capital allocation strategy.

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IBM
17% Buy83% Sell
Avg holding period · 88 Days
RLAY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About International Business Machines Corp

International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.

Read more on IBM →

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →